TLR5 and type 2 diabetes mellitus: Together, we present a novel pathway linking bacterial flagellin from the Gram-negative E. cloacae in a TLR5-macrophage-dependent manner to beta-cell inflammation and beta-cell dysfunction, suggesting a new mechanism linking gut microbiota and T2D prevalence and opening up potential avenues for novel therapies.